Skip to main content
. 2021 May 20;1(3):100026. doi: 10.1016/j.xjidi.2021.100026

Table 5.

Summary of the Number of Petechiae in Verruca Vulgaris Lesions in Each Subgroup

FIT039 (n = 13) Placebo (n = 11) Group Comparison
Time Point n n1 Mean (SD) Change from Day 1 (95% CI) (%) n n1 Mean (SD) Change from Day 1 (95% CI) (%) Difference in Change from Day 1 (95% CI) (%) P-Value
Day 1 13 7 15.35 (24.16) N/A 11 9 9.68 (11.41) N/A N/A N/A
Day 8 13 7 10.04 (16.15) 59.04 (20.92–97.16) 11 9 5.45 (8.84) 71.56 (5.16–137.96) –12.51 (–88.88 to 63.86) 0.731
Day 15 13 7 8.65 (12.97) 65.24 (3.87–126.61) 11 9 3.32 (4.83) 28.96 (4.93–52.99) 36.28 (–17.17 to 89.73) 0.168
Day 29 13 7 15.42 (30.13) 66.10 (17.00–115.20) 11 9 4.59 (6.63) 66.76 (–2.58 to 136.10) –0.66 (–83.38 to 82.06) 0.987
Day 43 13 7 12.81 (23.62) 66.58 (27.56–105.61) 11 9 6.00 (8.93) 91.12 (–12.11 to 194.35) –24.54 (–138.26 to 89.18) 0.651
Day 57 13 7 11.27 (19.14) 66.09 (17.55–114.63) 11 9 5.77 (8.79) 51.91 (19.05–84.78) 14.18 (–35.81 to 65.16) 0.560

Abbreviations: CI, confidence interval; N/A, not applicable.

Change from day 1 (%) = ([value at each time point]/[value on day 1]) × 100.

Day 1 is defined as the day of application of the skin patch.

1

Target verruca vulgaris lesions having petechiae were subjected to analysis.